0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita]

Verify with CMS →

adalimumab-atto

RxCUI: 2627717

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
0.1%
Plan Coverage
4
Plans Covering
T5
Avg Tier
100%
Prior Auth Required

What the CMS Formulary Data Shows for 0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita]

Per the CMS 2026 Part D formulary file, 0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] (RxNorm concept RXCUI 2627717, generic name adalimumab-atto) appears on 1 distinct formulary file spanning 4 Medicare Part D plan offerings - 0.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 5 to Tier 5, with a cross-plan average of Tier 5.

Real-world access to 0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] today.

Coverage Details

Formularies covering
1
Plans covering
4
Coverage rate
0.1%
Tier range
Tier 5, Specialty
Average tier
Tier 5, Specialty

Restrictions

Prior authorization required
100% of formularies
Step therapy required
0% of formularies
Quantity limits
0% of formularies

Tier Distribution Across Plans

4 plans
Tier 5, Specialty

Medicare Advantage Plans (MA-PD) Covering 0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita]

4 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
Presbyterian Senior Care Plan 2 with Rx (HMO) PRESBYTERIAN HEALTH PLAN T5 Yes $0 NM
Presbyterian Dual Plus (HMO D-SNP) PRESBYTERIAN HEALTH PLAN T5 Yes $0 NM
Presbyterian Senior Care Extra Health Plan with Rx (HMO) PRESBYTERIAN HEALTH PLAN T5 Yes $0 NM
Presbyterian Senior Care Plan 3 with Rx (HMO) PRESBYTERIAN HEALTH PLAN T5 Yes $65.80 NM

Frequently Asked Questions

Is 0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] covered by Medicare Part D?

Yes, 0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] is covered by 4 Medicare Part D plans (0.1% of all Part D formularies).

What tier is 0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] on Medicare Part D plans?

0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] averages Tier 5 across Part D plans, ranging from Tier 5 to Tier 5.

Does 0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita] require prior authorization?

100% of Part D formularies require prior authorization for 0.4 ML adalimumab-atto 50 MG/ML Prefilled Syringe [Amjevita]. Step therapy: 0%. Quantity limits: 0%.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial